Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors
Sara Belga(University of British Columbia), William A. Werbel(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Dorry L. Segev(New York University), Avonne E. Connor(Johns Hopkins University), Robert D. Levy(University of British Columbia), Errol L. Bush(Johns Hopkins University), Zeba Nauroz(Johns Hopkins University), Elizabeth A. King(Johns Hopkins University), Sarah Hussain(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), Pali Shah(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore)
Cited by 2
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k